✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
591daili 济南圣和化工
首页 › 产品目录 › 巴瑞克替尼

巴瑞克替尼

CAS 1187594-09-7C16H17N7O2SMW 371.4

巴瑞克替尼,CAS 登记号 1187594-09-7,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号1187594-09-7
分子式C16H17N7O2S
分子量371.4
沸点707.2
LogP-0.5
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域医药中间体及原料药
类别医药中间体及原料药

用途与场景

医药中间体及原料药

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 巴瑞克替尼 的 CAS 号?

本页已列出 巴瑞克替尼 的 CAS 号:1187594-09-7,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

巴瑞克替尼 一般用在什么产品里?

主要涉及医药中间体及原料药。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Baricitinib · CAS 1187594-09-7 · C16H17N7O2S. UNII ISP4442I3Y. Boiling Point: 707.2.

Identification

CAS Registry Number1187594-09-7
PubChem CID44205240
Molecular formulaC16H17N7O2S
IUPAC name2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile
UNII (FDA)ISP4442I3Y

Computed Descriptors

Molecular Weight371.4
XLogP3-0.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass371.11644398
Monoisotopic Mass371.11644398
Topological Polar Surface Area129
Heavy Atom Count26
Formal Charge0

Physical & Chemical Properties

Boiling Point707.2

GHS Hazard Classification

Reported hazard statementsH302 (50%), H335 (16.7%), H360 (66.7%), H372 (16.7%), H373 (66.7%), H411 (66.7%)

H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]

H335 (16.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

Documented Uses

  • Baricitinib is a disease-modifying antirheumatic drug (DMARD) indicated for rheumatoid arthritis when conventional DMARDs prove inadequate.
  • Baricitinib is an orally available small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis, severe alopecia areata, and, in combination with remdesivir, severe COVID-19 in hospitalized patients requiring supplementary oxygen. Baricitinib is associated with transient and usually mild elevations in serum aminotransferase levels during therapy but has yet to be linked to cases of clinically apparent acute liver injury.
  • Breast Feeding; Lactation; Milk, Human; Antirheumatic Agents; Enzyme Inhibitors; Janus Kinase Inhibitors; JAK Inhibitors; Signal Transduction Inhibitors; Protein Kinase Inhibitors
  • Baricitinib (Class: Other Substances, Added Date: 03-2022)
  • Take with or without food. A high-fat meal can decrease the mean AUC and Cmax of baricitinib and delay Tmax, but not to a clinically singificant extent.
  • Established Pharmacologic Class [EPC] - Janus Kinase Inhibitor

Synonyms

Baricitinib; 1187594-09-7; olumiant; LY3009104; INCB028050; INCB 028050; INCB-028050; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; LY-3009104; LY 3009104; ISP4442I3Y; DTXCID5074719; CHEBI:95341; DTXSID30152228; L04AA37; 3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-

Frequently Asked Questions

What are the CAS number and molecular formula of Baricitinib?

CAS 1187594-09-7; molecular formula C16H17N7O2S; molecular weight — g/mol.

What other names is Baricitinib known by?

Baricitinib, 1187594-09-7, olumiant, LY3009104, INCB028050, INCB 028050.

Is Baricitinib classified as hazardous?

Hazard statements reported: H302, H335, H360, H372, H373.

What are the key physical properties of Baricitinib?

Boiling Point: 707.2.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 巴瑞克替尼 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1